Given the strength of the association with Venetoclax sensitization we hypothesized that pharmacological inhibition of CREBBPWT function could sensitize CREBBPWT B-ALL to BCL2 inhibitors. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.